Literature DB >> 19205842

Redistribution of whole-body energy metabolism by exercise: a positron emission tomography study.

Md Mehedi Masud1, Toshihiko Fujimoto, Masayasu Miyake, Shoichi Watanuki, Masatoshi Itoh, Manabu Tashiro.   

Abstract

OBJECTIVE: Our aim was to evaluate changes in glucose metabolism of skeletal muscles and viscera induced by different workloads using (18)F-2-fluoro-2-deoxyglucose ([(18)F]FDG) and three-dimensional positron emission tomography (3-D PET).
METHODS: Five male volunteers performed ergometer bicycle exercise for 40 min at 40% and 70% of the maximal O(2) consumption (VO(2max)). [(18)F]FDG was injected 10 min later following the exercise task. Wholebody 3-D PET was performed. Five other male volunteers were studied as a control to compare with the exercise group. The PET image data were analyzed using manually defined regions of interest to quantify the regional metabolic rate of glucose (rMRGlc). Group comparisons were made using analysis of variance, and significant differences (P < 0.05) were determined using Scheffe's test (post hoc analysis).
RESULTS: Quantitative analysis demonstrated that rMRGlc increased (P < 0.05) in the skeletal muscles of the thigh at mild or moderate workloads when compared with the resting controls. For visceral organs such as the liver and brain, metabolic reduction was significant (P < 0.05) at mild and/or moderate exercise workload.
CONCLUSIONS: The present study demonstrated linear increases or decreases in glucose uptake by skeletal muscles and viscera with mild and moderate exercise workloads, suggesting the presence of homeostatic energy metabolism. This result supports the finding that [(18)F]FDG-PET can be used as an index of organ energy metabolism for moderate exercise workloads (70% VO(2max)). The results of this investigation may contribute to sports medicine and rehabilitation science.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205842     DOI: 10.1007/s12149-008-0212-6

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  7 in total

1.  Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.

Authors:  M D Goncalves; S Taylor; D F Halpenny; E Schwitzer; S Gandelman; J Jackson; A Lukose; A J Plodkowski; K S Tan; M Dunphy; L W Jones; R J Downey
Journal:  Clin Radiol       Date:  2018-01-06       Impact factor: 2.350

2.  Regional Variation in Skeletal Muscle and Adipose Tissue FDG Uptake Using PET/CT and Their Relation to BMI.

Authors:  Marcus D Goncalves; Judith Green-McKenzie; Abass Alavi; Drew A Torigian
Journal:  Acad Radiol       Date:  2017-05-24       Impact factor: 3.173

3.  Effect of exercise on burn-induced changes in tissue-specific glucose metabolism.

Authors:  Edward A Carter; Kasie Paul; Ali A Bonab; Ronald G Tompkins; Alan J Fischman
Journal:  J Burn Care Res       Date:  2014 Nov-Dec       Impact factor: 1.845

Review 4.  Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

5.  Rationale and methods to characterize the acute exercise response in aging and Alzheimer's Disease: the AEROBIC pilot study.

Authors:  Zachary D Green; Casey S John; Paul J Kueck; Jeffrey M Burns; Mark Perry; Joseph Donald; Jonathan D Mahnken; Robyn A Honea; Eric D Vidoni; Jill K Morris
Journal:  Contemp Clin Trials       Date:  2021-05-27       Impact factor: 2.226

6.  A tutorial on oxidative stress and redox signaling with application to exercise and sedentariness.

Authors:  Robert Buresh; Kris Berg
Journal:  Sports Med Open       Date:  2015-01-20

7.  Increasing exercise intensity reduces heterogeneity of glucose uptake in human skeletal muscles.

Authors:  Ilkka Heinonen; Sergey V Nesterov; Jukka Kemppainen; Toshihiko Fujimoto; Juhani Knuuti; Kari K Kalliokoski
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.